MALATHION Drug Patent Profile
✉ Email this page to a colleague
When do Malathion patents expire, and what generic alternatives are available?
Malathion is a drug marketed by Mylan Pharms Inc and Suven Pharms and is included in two NDAs.
The generic ingredient in MALATHION is malathion. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the malathion profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Malathion
A generic version of MALATHION was approved as malathion by SUVEN PHARMS on May 23rd, 2012.
Summary for MALATHION
Recent Clinical Trials for MALATHION
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| London School of Hygiene and Tropical Medicine | Phase 3 |
| Taro Pharmaceuticals USA | Phase 1 |
| Taro Pharmaceuticals USA | Phase 2/Phase 3 |
Pharmacology for MALATHION
| Drug Class | Cholinesterase Inhibitor |
| Mechanism of Action | Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for MALATHION
Anatomical Therapeutic Chemical (ATC) Classes for MALATHION
US Patents and Regulatory Information for MALATHION
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | MALATHION | malathion | LOTION;TOPICAL | 078743-001 | Mar 6, 2009 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Suven Pharms | MALATHION | malathion | LOTION;TOPICAL | 091559-001 | May 23, 2012 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
